A novel thromboxane receptor antagonist and synthase inhibitor, BM-573, reduces development and progression of atherosclerosis in LDL receptor deficient mice. (Q64987425)
Jump to navigation
Jump to search
scientific article published on 19 January 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A novel thromboxane receptor antagonist and synthase inhibitor, BM-573, reduces development and progression of atherosclerosis in LDL receptor deficient mice. |
scientific article published on 19 January 2007 |
Statements
A novel thromboxane receptor antagonist and synthase inhibitor, BM-573, reduces development and progression of atherosclerosis in LDL receptor deficient mice. (English)
1 reference
Tillmann Cyrus
1 reference
Yuemang Yao
1 reference
Tao Ding
1 reference
Jean Michel Dogné
1 reference
Domenico Praticò
1 reference
19 January 2007
1 reference
561
1 reference
105-111
1 reference
1-3
1 reference
Identifiers
1 reference